Showing results (21-30 of 119) with videos related to
Sort By:
Pageof 12
Infection and Immunity|May 1, 1996
Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated miceA R Melton-Celsa, S C Darnell, A D O'BrienMicrobiology Spectrum|April 6, 2023
Shiga Toxin (Stx) Phage-Encoded Lytic Genes Are Not Required for the Mouse Virulence of O157:H7 Escherichia coli Stx2-Producing Clinical IsolatesR R Atitkar, J R Hauser, A R Melton-CelsaNature|August 23, 2002
A saponin-detoxifying enzyme mediates suppression of plant defencesK Bouarab, R Melton, J Peart, et al.International Journal of Oncology|May 5, 2011
Antibody-directed enzyme prodrug therapy (ADEPT)B Retta, P Burke, A Photiou, et al.Toxins|November 13, 2013
Shiga toxin type 2dact displays increased binding to globotriaosylceramide in vitro and increased lethality in mice after activation by elastaseJoshua C Bunger, Angela R Melton-Celsa, Alison D O'BrienMicrobial Pathogenesis|March 13, 2003
Mutations in hns reduce the adherence of Shiga toxin-producing E. coli 091:H21 strain B2F1 to human colonic epithelial cells and increase the production of hemolysinMaria E Scott, Angela R Melton-Celsa, Alison D O'BrienGut Microbes|August 31, 2013
When a healthy diet turns deadlySteven D Zumbrun, Angela R Melton-Celsa, Alison D O'BrienThe Journal of Infectious Diseases|January 9, 2016
Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2aLisa M Russo, Angela R Melton-Celsa, Alison D O'BrienEcosal Plus|October 8, 2015
Shiga Toxins: Potent Poisons, Pathogenicity Determinants, and Pharmacological AgentsA R Melton-Celsa, M J Smith, A D O'BrienMolecular Microbiology|February 19, 2002
Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamerAngela R Melton-Celsa, John F Kokai-Kun, Alison D O'BrienPageof 12